Editing Kynurenine
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
The edit can be undone. Please check the comparison below to verify that this is what you want to do, and then publish the changes below to finish undoing the edit.
Latest revision | Your text | ||
Line 8: | Line 8: | ||
* reduced [[cognitive dysfunction|brain fog]] | * reduced [[cognitive dysfunction|brain fog]] | ||
* reduced [[Memory problems|memory impairment]], and Β | * reduced [[Memory problems|memory impairment]], and Β | ||
* improvements in [[headache]] symptoms<ref name=OMF26May2020>{{Cite web|url=https://www.omf.ngo/2020/05/26/omf-announces-new-treatment-trial/ | title = OMF Announces New Treatment Trial | date = 2020-05-26 | last = Open Medicine Foundation | | * improvements in [[headache]] symptoms<ref name=OMF26May2020>{{Cite web|url=https://www.omf.ngo/2020/05/26/omf-announces-new-treatment-trial/ | title = OMF Announces New Treatment Trial | date = 2020-05-26 | last = Open Medicine Foundation | author-link=Open Medicine Foundation|language=en-US|access-date=2020-07-03}}</ref> | ||
==Uppsala trial, Sweden == | ==Uppsala trial, Sweden == |